Regional Variation in Patients and Outcomes in the Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist (TOPCAT) Trial

Pfeffer et al. (Tue,) studied this question.

www.synapsesocial.com/papers/69d575396e4506aa303c1461 — DOI: https://doi.org/10.1161/circulationaha.114.013255

Also consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. Influence of Nonfatal Hospitalization for Heart Failure on Subsequent Mortality in Patients With Chronic Heart Failure· 2007 · 669 citations
2. Defining Diastolic Heart Failure and Identifying Effective Therapies· 2013 · 41 citations
3. United States Life Tables, 2019.· 2022 · 498 citations
4. Impact of Noncardiac Comorbidities on Morbidity and Mortality in a Predominantly Male Population With Heart Failure and Preserved Versus Reduced Ejection Fraction· 2012 · 683 citations
5. Risk Following Hospitalization in Stable Chronic Systolic Heart Failure· 2013 · 47 citations